Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
- The Scale for the Assessment of Negative Symptoms.University of Iowa, New York1983
- Minute-by-minute analysis of REM sleep timing in major depression.Biol Psychiatry. 1990; 28: 911-925
- A specific laboratory test for the diagnosis of melancholia: Standardization, validation, and clinical utility.Arch Gen Psychiatry. 1981; 38: 15-22
- Abnormal dexamethasone suppression test results in chronic schizophrenic patients.Am J Psychiatry. 1982; 139: 1501-1503
- A rating scale for depression.J Neurol Neurosurg Psychiatry. 1960; 23: 56-62
- Clozapine for the treatment-resistant schizophrenic: A double-blind comparison with chlorpromazine.Arch Gen Psychiatry. 1988; 45: 789-796
- Schizophrenia subdivided by the family history of affective disorder.Arch Gen Psychiatry. 1983; 40: 951-955
- Sleep abnormalities in schizophrenia: Pathophysiological significance.Psychol Med. 1993; 23 ([editorial]): 831-835
- EEG sleep in familial subgroups of schizophrenia.Sleep Res. 1990; 19: 330
- The brief psychiatric rating scale.Psychol Rep. 1962; 10: 799-812
- Sleep research in affective illness: State of the art circa 1987.Sleep. 1987; 10: 199-215
- Relationships between brain CT scan findings and cortisol in psychotic and nonpsychotic depressed patients.Biol Psychiatry. 1989; 26: 565-575
- Cholinergic hyperactivity and negative schizophrenic symptoms.Arch Gen Psychiatry. 1989; 46: 745-753
- Dexamethasone suppression test in schizophrenia: Relationship to symptomatology, ventricular enlargement, and outcome.Biol Psychiatry. 1991; 29: 953-964
- Electroencephalographic sleep abnormalities in schizophrenia: Relationship to positive/negative symptoms and prior neuroleptic treatment.Arch Gen Psychiatry. 1992; 49: 185-194
- Abnormal rapid eye movement latencies in schizophrenia.Arch Gen Psychiatry. 1987; 44: 45-48
This work was presented at the 49th annual convention of the Society of Biological Psychiatry, Philadelphia, Pennsylvania, May 18–22, 1994.
This work was supported by grants from the National Institute of Mental Health (MH-029118), NARSAD, and the Scottish Rite Schizophrenia Research Program.